- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Revolution Medicines Inc (RVMD)
Revolution Medicines Inc stock price live, this page displays NASDAQ RVMD stock exchange data. View the RVMD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Revolution Medicines Inc real time stock price chart below.
What Is the Revolution Medicines Inc Stock Price Today?
The Revolution Medicines Inc stock price today is 152.62.
What Is the Stock Symbol for Revolution Medicines Inc?
The stock ticker symbol for Revolution Medicines Inc is RVMD.
Is RVMD the Same as $RVMD?
$RVMD is a common way to refer to the Revolution Medicines Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Revolution Medicines Inc Trade On?
Revolution Medicines Inc is listed and trades on the NASDAQ stock exchange.
Is Revolution Medicines Inc a Good Stock to Buy?
Determining whether Revolution Medicines Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Revolution Medicines Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RVMD quote. (ISIN: US76155X1000)
What Is the Revolution Medicines Inc Stock Price Today?
The Revolution Medicines Inc stock price today is 152.62.
What Is the Stock Symbol for Revolution Medicines Inc?
The stock ticker symbol for Revolution Medicines Inc is RVMD.
Is RVMD the Same as $RVMD?
$RVMD is a common way to refer to the Revolution Medicines Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Revolution Medicines Inc Trade On?
Revolution Medicines Inc is listed and trades on the NASDAQ stock exchange.
Is Revolution Medicines Inc a Good Stock to Buy?
Determining whether Revolution Medicines Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Revolution Medicines Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RVMD quote. (ISIN: US76155X1000)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
147.63
155.01
52 wk Range
34.00
155.01
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
147.63155.01
52 wk Range
34.00155.01
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RVMD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
157.58
Upside
+3.25%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Revolution Medicines Inc SWOT Analysis
Analyst Perspectives | Price targets range from $67 to $99, reflecting varied views on RVMD's growth potential and the $8 billion market opportunity for daraxonrasi |
Market Positioning | Explore how Revolution Medicines is navigating the competitive RAS inhibitor landscape with its multi-target approach and potential for combination therapies |
Financial Outlook | Despite negative EPS forecasts, RVMD maintains strong liquidity with a current ratio of 11.79, positioning it well for ongoing clinical development |
Promising Pipeline | Revolution Medicines' daraxonrasib shows potential in PDAC and NSCLC treatments, with pivotal trials set for 2025-2026 and impressive response rates |
Revolution Medicines Inc Earnings Call Summary for Q4/2025
- Revolution Medicines ended Q4 2025 with $2.03B in cash, bolstered by Royalty Pharma partnership providing up to $2B in committed capital.
- Net loss surged 87% YoY to $364.9M; R&D expenses jumped 57% to $294.9M as company advances eight Phase 3 trials in oncology treatments.
- Company shifts guidance focus to operating expenses, projecting $1.6B-$1.7B in GAAP operating expenses for 2026 amid aggressive clinical investment.
- Key RASolute 302 trial results for pancreatic cancer expected in H1 2026, critical milestone for company's oncology pipeline development.
- Stock gained 150% over past year despite 87% loss increase; analysts maintain strong buy consensus with price targets ranging $73-$170.
Last Updated: 02/25/2026, 05:52 PM
Read Full TranscriptCompare RVMD to Peers and Sector
Metrics to compare | RVMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRVMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −27.0x | −6.3x | −0.5x | |
PEG Ratio | 0.41 | −0.09 | 0.00 | |
Price / Book | 18.7x | 5.1x | 2.6x | |
Price / LTM Sales | - | 118.0x | 3.2x | |
Upside (Analyst Target) | 5.5% | 45.4% | 47.6% | |
Fair Value Upside | Unlock | −3.6% | 6.1% | Unlock |
Analyst Ratings
21 Buy
0 Hold
0 Sell
Ratings:
21 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 157.58
(+3.25% Upside)
Earnings
Latest Release
Feb 25, 2026
EPS / Forecast
-1.86 / -1.58
Revenue / Forecast
-- / 3.89M
People Also Watch
FAQ
What Is the Revolution Med (RVMD) Stock Price Today?
The Revolution Med stock price today is 152.62 USD.
What Stock Exchange Does Revolution Med Trade On?
Revolution Med is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Revolution Med?
The stock symbol for Revolution Med is "RVMD."
What Is the Revolution Med Market Cap?
As of today, Revolution Med market cap is 30.39B USD.
What Is Revolution Med's Earnings Per Share (TTM)?
The Revolution Med EPS (TTM) is -5.95.
When Is the Next Revolution Med Earnings Date?
Revolution Med will release its next earnings report on May 11, 2026.
From a Technical Analysis Perspective, Is RVMD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Revolution Med Stock Split?
Revolution Med has split 0 times.
How Many Employees Does Revolution Med Have?
Revolution Med has 883 employees.
What is the current trading status of Revolution Med (RVMD)?
As of Apr 15, 2026, Revolution Med (RVMD) is trading at a price of 152.62 USD, with a previous close of 147.01 USD. The stock has fluctuated within a day range of 147.63 USD to 155.01 USD, while its 52-week range spans from 34.00 USD to 155.01 USD.
What Is Revolution Med (RVMD) Price Target According to Analysts?
The average 12-month price target for Revolution Med is 157.58 USD, with a high estimate of 200 USD and a low estimate of 116 USD. 21 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +3.25% Upside potential.
What Is the RVMD Premarket Price?
RVMD's last pre-market stock price is 149.38 USD. The pre-market share volume is 476,880.00, and the stock has decreased by 2.37, or 1.61%.
What Is the RVMD After Hours Price?
RVMD's last after hours stock price is 152.51 USD, the stock has decreased by -0.03, or -0.02%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.